BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Emerging Biotech

Medigen's MVC-COV1901 Selected for WHO COVID-19 Solidarity Trial Vaccines

The announcement by WHO, comes after the approval from WHO Ethics Review Committee and relevant regulatory authorities and ethics committees of&n...

October 27, 2021 | News

AION Labs, Biotech Innovation Lab Launched by Top Pharma, Tech and Investment Leaders

AION Labs, a first-of-its-kind innovation lab spearheading the adoption of AI technologies and computational science to solve therapeutic challenges, today...

October 14, 2021 | News

RMG-KB BIOACCESS FUND LAUNCHES with Worldwide Focus on Innovative Life Sciences Ventures

This latest fund represents a significant expansion of the principal investment business of RMG, building on the team's 25-plus year history in life scienc...

September 08, 2021 | News

Neukio Biotherapeutics completed its $40m Angel round financing

Neukio Biotherapeutics, a newly established company, recently announced the completion of its $40m Angel round of financing led by Lilly Asi...

July 30, 2021 | News

Gilead Sciences Announces Launch of Asia Pacific ALL4LIVER Grant 2021

– Inaugural Cycle of the Grant will Focus on Hepatitis B Awareness Initiatives – Gilead Sciences, Inc. today announced th...

July 28, 2021 | News

LISCure, the first Korean biotech company receiving equity investment from Mayo Clinic

LISCure Biosciences, Inc. ("LISCure") has entered into a know-how license and development collaboration agreement, and stock purchase agreement with Mayo C...

July 26, 2021 | News

Swiss biotech innovation on the global stage

The Swiss National Startup Team welcomes new members: A jury selected 10 startups for the first Venture Leaders program dedicated explicitly to the biotech...

July 15, 2021 | News | By Isabelle Mitchell

Medix Biochemica expands its monoclonal antibody offering

Medix Biochemica has acquired 100 percent of the shares of Diaclone, a prominent provider of monoclonal antibodies in the areas of inflammation, oncology...

July 14, 2021 | News

Sartorius strengthens product portfolio by acquiring CellGenix

The life science group Sartorius, through its subgroup Sartorius Stedim Biotech, has acquired a majority stake in the reagent manufacturer CellGenix GmbH. ...

July 02, 2021 | News

Cytiva acquires Intermountain Life Sciences

Global life sciences leader Cytiva has acquired Intermountain Life Sciences, a manufacturer of high-purity water, buffers, and liquid cell culture med...

June 30, 2021 | News

Merck and B. Braun Join Forces in the Development of Bioelectronic Devices

Merck, a leading science and technology company, today announced a collaboration in its new Bioelectronics innovation field with neuroloop GmbH – a B...

June 30, 2021 | News

Innovent Announces An Agreement with Synaffix

Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medi...

June 29, 2021 | News

Australia's Qbiotics concludes successful $85 million capital raise

Capital raise nets $85 million from Existing Shareholders, Existing Institutional Investors, and cornerstone investor TDM Growth Partners. Fun...

June 28, 2021 | News

Nucleai and Merck Launch Translational Medicine Collaboration

Nucleai (www.nucleaimd.com), a precision medicine company using AI-powered image analysis technology to support novel pathology-based biomarker development...

June 25, 2021 | News

Stay Connected